Preliminary studies in mice have confirmed potential benefits for obesity. Here in this study, they focused on diabetic obese mice that had fatty liver disease. This is a population base that is on a significant rise for humans. The mice that were given hyperbaric oxygenation therapy, had a significantly lower body weight than those of the control group. The authors concluded that HBOT has the advantage of improving obesity in patients with metabolic syndrome. The only disadvantage was greater oxidative damage that would occur in the liver. This could easily be rectified with proper dosing of oxygen and proper nutritional therapy for antioxidant protection at the time of delivery. Hyperbaric oxygen therapy, has already been researched for helping the diabetic population, in many ways (like wound healing, cardiovascular disease, heart attacks, blood sugar control, and much more); Now, we can add metabolic syndrome to the equation <view study> Read Less

It is well researched that diabetics can benefit from hyperbaric oxygen therapy as a primary treatment for foot wounds, ulcers, and other hard to heal injuries. However, the major complication to diabetics is in cardiovascular disease and coronary events (CE) like sudden heart attacks, strokes, etc. The main contributing factors to this elevated risk are poor glycemic control, elevated inflammatory markers and atherosclerosis. In this study, they monitored these factors in diabetics being treated with HBOT for diabetic foot wounds. With no surprise, all parameters including fasting blood sugar, haemoglobin H1C, CRP, and lipid profiles were statistically significantly improved. The researchers concluded that the application of HBOT caused better glycemic control and had beneficial effects on atherosclerosis. With this, HBOT may be the answer in reducing risk of CE’s and therefore reducing both debilities and mortalities that are commonly observed in the diabetic population <view study> Read Less